Project Grant R01AG088223

Award Date 7/1/24
Completion Date 6/30/28
Dollars Obligated $526K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98109, USA
Similar Awards
This $312,900 Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) supports research to identify the genetic basis of extraordinary lifespan in a model organism, the nematode Caenorhabditis elegans. The 5-year project aims to: (1) discover the genetic variants responsible for longevity in a naturally occurring long-lived C. elegans isolate, (2) analyze how natural variation affects lifespan and develop tissue-specific "aging...
Duke University received a $1,019,484.58 Project Grant award from the National Institutes of Health's National Institute on Aging under the Aging Research program (CFDA 93.866) for the period September 1, 2021 through May 31, 2022. The award will support research using the nematode C. elegans as a model organism to study aging-associated neurodegeneration at the molecular level, with the goals of uncovering novel mechanisms underlying this process and establishing C. elegans neurons as a...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) program, provides $227,250 to Saint Louis University to conduct research on the role of the protease Cathepsin L in modulating the nuclear proteome, including key architectural proteins like lamins, under conditions of cellular stress and nuclear damage. The overarching goal is to elucidate how Cathepsin L-mediated remodeling of the nuclear proteome can both mitigate and exacerbate...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,102,269 to the University of Illinois to conduct research aimed at understanding the relationship between precocious neuronal differentiation and early-onset neurodegeneration. The project will utilize the C. elegans model system to investigate how heterochronic gene mutations, such as lin-41 and lin-14, that cause precocious neuronal differentiation can subsequently lead to early-onset...
This $1,044,855 Project Grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund Nemalife Inc. to deliver high-throughput testing of anti-aging and FDA-approved drugs in genetically diverse invertebrate Alzheimer's disease models. Under the Aging Research program (CFDA 93.866), the awardee will screen 300 anti-aging compounds and 200 FDA drugs to identify candidates that improve neuronal aging and protect against protein misfolding diseases...
This Project Grant award of $395,796 from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research at Brown University to develop genetic, pharmacological, and dietary interventions that delay the onset and progression of age-related diseases. The key objectives are to: 1) Investigate the interconnectedness and hierarchical structure of the hallmarks of aging, such as loss of genomic integrity, activation of retrotransposons, and accumulation of lipid droplets; 2)...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $656,709 to Yale University to conduct research on the mechanism of nucleophagy, a process of nuclear envelope rejuvenation, over a 5-year period from December 1, 2024 to November 30, 2029. The research aims to define the molecular and ultrastructural steps of nucleophagy using the S. cerevisiae model, integrate the identified molecular machineries, and test the hypothesis that...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $1,359,000.00 to Baylor College of Medicine to conduct research on age-associated cellular and molecular adaptations that enable whole-organism rejuvenation in the highly regenerative flatworm Schmidtea mediterranea. The research aims to (1) determine how age-associated damage manifests in asexual planaria throughout their lifecycle...
The National Institute on Aging awarded a $387,068 Project Grant under its Aging Research federal grant program (CFDA 93.866) to the Icahn School of Medicine at Mount Sinai (ISMMS) to investigate the mechanisms underlying cellular rejuvenation during oogenesis. The project aims to define the spatiotemporal dynamics of nuclear pore complex (NPC) turnover, determine the factors that promote NPC rejuvenation, and assess the biological relevance of these NPC rejuvenation pathways to oocyte...
The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $506,404 project grant to The Trustees of the University of Pennsylvania to conduct research on the role of chromatin and epigenetic mechanisms in regulating senescence and aging. The 5-year project (1/1/2025 - 12/31/2029) will investigate: 1) how enhancer rewiring and the formation of large enhancer communities drive gene expression changes during senescence; 2) the mechanisms behind...

TISSUE MECHANISMS OF AGING IN THE GENETIC MODEL C. ELEGANS - PROJECT SUMMARY/ABSTRACT THE NEMATODE C. ELEGANS IS A LEADING EXPERIMENTAL AND GENETIC MODEL FOR AGING, AND BOTH PUBLIC AND PRIVATE INSTITUTIONS HAVE MADE ENORMOUS INVESTMENTS IN AGING RESEARCH IN THIS SYSTEM. SEVERAL LINES OF EVIDENCE SHOW THAT THE INTESTINE IS THE MAJOR TISSUE AFFECTING HEALTHY LIFESPAN IN C. ELEGANS. THE INTESTINE IS LIKELY TO BE A SENSITIVE AND EARLY INDICATOR OF AGE-DEPENDENT CELLULAR STRESS, AS THE INTESTINE LACKS AN APOPTOSIS PATHWAY OR STEM CELL POPULATION TO REMOVE OR REPLACE DAMAGED CELLS. INTESTINAL NUCLEI HAVE BEEN SHOWN TO UNDERGO PROGRESSIVE DETERIORATION DURING AGING, INCLUDING THE LOSS OF ENTIRE NUCLEI. OLD, ABNORMAL INTESTINAL NUCLEI SHOW A LOSS OF PERIPHERAL HETEROCHROMATIN, A DISRUPTION OF CHROMOSOMAL ORGANIZATION, AND THE ACCUMULATION OF INTRANUCLEAR BODIES THAT CONTAIN THE PROTEIN LAMIN. RECENT STUDIES SHOWED THAT SOME INTESTINAL NUCLEI SHOW ABNORMALITIES AS EARLY AS THE FIRST TWO DAYS OF ADULTHOOD, AND THAT THESE EARLY ABNORMALITIES INCLUDE THE FORMATION OF LAMIN-CONTAINING NUCLEAR BODIES AND THE LOSS OF PERIPHERAL HETEROCHROMATIN. BECAUSE THESE DEFECTS OCCUR EARLY IN DEVELOPMENT, THEY ARE LIKELY TO REPRESENT CRITICAL EVENTS THAT DRIVE NUCLEAR DETERIORATION DURING AGING, RATHER THAN INDIRECT CONSEQUENCES OF AGE-COMPROMISED CELLS. SOME OF THE INTRANUCLEAR LAMIN AND LOSS OF PERIPHERAL HETEROCHROMATIN IS ASSOCIATED WITH FAT ACCUMULATION IN THE NUCLEUS, CALLED NUCLEAR LIPID DROPLETS OR NLDS. RECENT STUDIES HAVE SHOWN THAT DIVERSE LIVER DISEASES IN HUMANS ARE ASSOCIATED WITH INCREASED NUMBERS OF NLDS, AND NLDS IN C. ELEGANS HAVE BEEN SHOWN TO INCREASE DURING AGING. NLDS IN OTHER SYSTEMS SHOW A COMPLEX RELATIONSHIP WITH FAT, AND NLDS IN THE C. ELEGANS INTESTINE APPEAR TO BE CORRELATED WITH CHANGES IN LIPID STORAGE THAT OCCUR DURING REPRODUCTIVE DEVELOPMENT. THIS PROPOSAL INVESTIGATES THE ORIGIN OF INTRANUCLEAR LAMIN IN INTESTINAL CELLS, ITS RELATIONSHIP TO NLDS, AND THE ROLE OF LIPID STORAGE. THE RESEARCH USES C. ELEGANS TOOLS FOR FORWARD AND REVERSE GENETICS TO IDENTIFY PATHWAYS THAT CAUSE, OR ACT TO REMOVE, THE INTRANUCLEAR LAMIN. THE PROJECT ANALYZES SPECIFIC ROLES FOR TWO GENES WHICH ARE INVOLVED IN NLD FORMATION AND THAT ARE CONSERVED IN HUMANS. THE LONG-TERM GOAL OF THE PROJECT IS TO DEVELOP STRATEGIES THAT MODULATE THESE PATHWAYS TO INTERVENE IN AGE-ASSOCIATED TISSUE DETERIORATION.

Posted 6/25/24, 12:00 AM